A study of the mechanisms involved in imipenem resistance in Pseudomonas aeruginosa isolates from Japan Sir, R ecently, there have been increasing reports from Japan of carbapenem-resistant clinical isolates belonging to both the E nterobacteriaceae and Pseudomonaceae families that produce a metallo--lactamase, designated IMP-1.
1,2
The bla IMP gene is carried on a novel integron-like element, and because of the transferable nature of this gene it has been speculated that carbapenem-resistant G ram-negative organisms, that produce IMP-1, may be prevalent in the near future.
2
A study was therefore undertaken to determine the mechanisms involved in imipenem resistance in 61 clinical Pseudom onas aeruginosa strains isolated from 21 different hospital centres in Japan, during 1994. The main emphasis was on establishing if IMP-1 -lactamase was implicated in the resistance mechanism or if a novel carbapenemase was present. The contribution of chromosomal cephalosporinases to imipenem resistance was also examined.
PCR analysis has previously been successfully applied for the detection of the bla IMP gene.
2 When the 61 P. aeruginosa isolates in this study were subjected to PCR with bla IMP specific primers they were all found to be negative for this apparently highly conserved gene. F u r t h e rmore, D NA hybridization with a 587 base pair intragenic bla IMP gene probe, generated by PCR , also confirmed these strains to be negative for an IMP-1-like enzyme.
Chromosomal cephalosporinases are ubiquitous amongst P. aeruginosa and by determining the MIC of imipenem alone and in the presence of a fixed concentration of the serine -lactamase inhibitor BR L42715, it was possible to show the contribution of the chromosomal cephalosporinase to imipenem resistance in the P. aeruginosa strains. In the presence of BR L42715, a 4-to 16-fold decrease in the MIC of imipenem is indicative of the involvement of a cephalosporinase in the mechanism of imipenem resistance 3 and was demonstrated in all but four of the 61 strains. The imipenem MIC for the IMP-1-producing control strain P. aeruginosa M18 was unaffected by BR L42715 and, therefore, the chromosomal cephalosporinase was not a contributing factor to the level of imipenem resistance in this isolate.
Isoelectric focusing of -lactamases from selected strains, followed by overlaying the gel with BR L42715 and clavulanic acid, a specific inhibitor of class A , but not class C -lactamases, provided further evidence that these strains possess a class C -lactamase, not a class A , that is involved in the imipenem resistance mechanism. It has previously been shown that derepressed class C cephalosporinases are able to hydrolyse imipenem, slowly but significantly.
4 D erepression of a class C -lactamase with the loss of the D 2 outer membrane porin is a well recognized mechanism of imipenem resistance. 4 H ydrolysis of imipenem could not be detected in either of those strains in which the imipenem MIC was unaffected by BR L42715, or on randomly selected strains that displayed a decrease in their imipenem MIC in the presence of BR L42715. Therefore, these results ruled out the involvement of a novel carbapenemase in the imipenem resistance mechanism.
It was also demonstrated that strains, which show a decrease in their imipenem MICs in the presence of BR L42715, are not necessarily derepressed for -lactamase activity. In fact, a decrease in the impenem MIC in the presence of BR L42715 is found in strains that are either constitutive or inducible producers of -lactamase. The four strains that were resistant to imipenem, but unaffected by BR L42715, also varied in the levels of -lactamase that they producd. H owever, in these strains imipenem resistance appears to be -lactamase independent and the effects of other porin species, or active efflux systems, may be contributing factors.
5
D etermining the mechanism of bacterial resistance to carbapenems in P. aeruginosa is a complex process. Synergy between a cephalosporinase and lowered outer membrane permeability is by far the most prevalent mechanism of carbapenem resistance in the strains studied in this survey, which also highlights that IMP-1-mediated mechanism of resistance is currently a much rarer event.
In the original Japanese report, 1 132 carbapenem-resistant P. aeruginosa strains were examined and 13% were found to carry the bla IMP gene. The carbapenem resistance mechanism in the remaining 87% was not determined and it is highly probable that the resistance mechanism in many of these strains that were not further investigated involved a cephalosporinase and a reduction in outer membrane permeability. R ecent findings indicate that the isolation of IMP-1-containing strains is still increasing; 6 however, it remains to be seen whether in the future this mechanism becomes as widespread in P. aeruginosa as the one that involves the combination of a class C -lactamase and impermeability. Sir, Multidrug-resistant salmonellae have emerged as important public health problems. Isolates are commonly resistant to chloramphenicol, tetracycline, co-trimoxazole, aminoglycosides and penicillins, and the plasmids that mediate resistance to these drugs have spread widely amongst Salm onella spp.
Emergence of resistance to third-generation cephalosporins amongst
1,2 More recently, there have been sporadic reports of strains that are also resistant to newer -lactams. [3] [4] [5] [6] We report here the first isolation in G reece of strains of Salm onella typhim urium resistant to oxyimino -lactams and describe the mechanisms of resistance to these antibiotics.
S. typhim urium strain A S30 was isolated in late 1996 from a 62 year old man with gastroenteritis. H e had emigrated from Southern R ussia 1 month before the pathogen was isolated and was living in A thens at the time. Strain A S31 was recovered in 1997 from an infant living in a settlement for immigrants near Thessaloniki. The third strain, E P112, was isolated in 1994 from a blood culture obtained from an infant treated at the 'A . Kyriakou' Childrens' H ospital in A thens. The isolates were identified with the A PI20E system (bioMérieux, Marcy l'E toile, France) and serotyped with O -, H 1 -and H 2 -specific antisera. MICs of the -lactams were determined by the E test method (Biodisk, Solna, Sweden) and susceptibility/resistance was defined according to breakpoints recommended by the National Committee for Clinical Laboratory Standards.
7 Susceptibility to other antibiotics was determined by the disc diffusion method. Transfer of resistance by conjugation was performed as described previously with E scherichia coli 14R 525 as the recipient.
8 Plasmid D NA was extracted by alkaline lysis and partial nucleotide sequencing of -lactamase genes was undertaken directly on the wild R -plasmids with the Sequenase 2.0 kit (U SB Corporation, Cleveland, O H , U SA ) with custom-synthesized primers specific for the bla SH V and bla CTX-M genes. Crude extracts of -lactamases were prepared by mild ultrasonic treatment of bacterial suspensions and isoelectric focusing was carried out in polyacrylamide gels containing ampholytes.
The susceptibilities and other characteristics of the three S. typhim urium strains are shown in the Table. A S30 and A S31 exhibited similar phenotypes, i.e., resistance to ampicillin, piperacillin, ceftriaxone, cefotaxime and aztreonam and susceptibility to ceftazidime and piperacillin/tazobactam. The MICs of co-amoxiclav for both strains closely approximated the resistance breakpoint and the double-disc diffusion test demonstrated enhancement of the activities of the oxyimino -lactams by clavulanic acid. Both isolates were also resistant to chloramphenicol, tetracycline, co-trimoxazole, gentamicin and tobramycin. E P112, on the other hand, was resistant to ampicillin, piperacillin, ceftazidime and aztreonam and exhibited reduced susceptibility to cefotaxime and ceftriaxone, but was susceptible to the -lactam/ -lactamase inhibitor combinations, co-amoxiclav and piperacillin/ tazobactam; the double-disc diffusion test confirmed that the strain was an extended-spectrum -lactamase (E SBL) producer. In common with A S30 and A S31, E P112 was resistant to chloramphenicol, co-trimoxazole, gentamicin and tobramycin. A ll three isolates were susceptible to ciprofloxacin.
